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eversible Atrioventricular Block
ssociated With Closure of Atrial
eptal Defects Using the Amplatzer Device
enji Suda, MD,* Marie-Jose´e Raboisson, MD,† Eric Piette, Nagib S. Dahdah, MD, FACC,‡
oaquim Miro´, MD, FRCP‡
enri, Japan; Lyon, France; and Montreal, Canada
OBJECTIVES We sought to determine the incidence, nature, and predisposing factors of atrioventricular
block (AVB) associated with closure of atrial septal defects (ASDs) using the Amplatzer
septal occluder (ASO).
BACKGROUND In our institution, 162 patients underwent ASD closure using ASO between December 1997
and December 2001. This includes small children with large defects.
METHODS Electrocardiographic tracings during ASO implantation and at follow-up visits were
reviewed. Anatomic characteristics and device size were assessed as potential risk factors for
AVB.
RESULTS Ten patients (6.2%) presented with new-onset (n  9) or aggravation of preexisting
(n 1) AVB. Atrioventricular block occurred during the procedure (n 3) or was first noted
one day to one week later (n  7). Patients had first-degree (n  4), second-degree
Wenckebach (n  4), or third-degree (n  2) AVB, with no symptoms or hemodynamic
compromise. First-degree AVB persisted in two patients at 12 and 33 months of follow-up,
whereas most recovered normal AV conduction within one (n  7) or six months (n  1).
A larger shunt (Qp/Qs ratio 2.8  0.9 vs. 2.1  0.8, p  0.01) and device size (24  5 vs.
19  6 mm, p  0.01) were the only determinant factors for AVB. A device size 19 mm
was used in 90% (9 of 10) of patients who developed AVB, as compared with 49% of those
without AVB (p  0.02).
CONCLUSIONS Closure of ASDs using the large ASO can be associated with the development of AV block
and mandate a closer follow-up. In our series, however, all AVBs resolved or improved
spontaneously, with no recurrence at mid-term follow-up. (J Am Coll Cardiol 2004;43:
1677–82) © 2004 by the American College of Cardiology FoundationM
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fercutaneous closure of ostium secundum atrial septal
efects (ASDs) has been widely accepted and is becoming
ne of the standard treatments of this malformation (1–6).
mong these devices, the Amplatzer septal occluder (ASO;
GA Medical Corp., Golden Valley, Minnesota) seems to
rovide the highest level of effectiveness and safety (1,7–10).
owever, some complications have been reported with the
se of the ASO, such as arrhythmia, embolization, throm-
us formation, pericardial effusion, and transient ischemic
ttack (4–6,10). Because of the close proximity between the
iscs of the device and the atrioventricular (AV) node (11),
trioventricular block (AVB) is a likely complication. How-
ver, limited data are available concerning AVB associated
ith ASD closure using the ASO (4–6,10,12). Therefore, the
im of this study was to determine the incidence, evolution,
nd predisposing factors of AVB associated with ASD closure
sing the ASO in a single-institution experience.
From the *Division of Pediatric Cardiology, Department of Pediatrics, Tenri
ospital, Tenri, Japan; †Department of Cardiology, Hoˆpital Louis Pradel, Lyon,
rance; and ‡Division of Cardiology, Hoˆpital Sainte-Justine, University of Montreal,
ontreal, Canada. This work was completed at Hoˆpital Sainte-Justine, University of
ontreal, Montreal, Canada.
Manuscript received July 30, 2003; revised manuscript received October 1, 2003,ccepted December 9, 2003.ETHODS
rom December 1, 1997, to December 31, 2001, 162
atients with ASDs underwent ASD closure using the ASO
t Sainte-Justine Hospital, Montreal. Before August 2000,
ome patients were referred for surgical closure without any
ttempt to close the defect via catheterization (n  16) or
fter a failed attempt (n  2). Since August 2000, all
atients with an isolated secundum ASD underwent suc-
essful ASD closure using the ASO, regardless of the defect
natomy (size, number of defects, or rim characteristics) or
he patient’s size and age. Among these patients, multiple
SDs were closed using a single device in 40 patients and
sing two devices in one patient with distant defects.
All patients had an electrocardiogram (ECG) before and
uring closure and at one day, one week, one month, three
onths, and yearly after the procedure, according to our
rotocol. Patients with second- or third-degree AVB were
urther evaluated on a daily or weekly basis until 1:1
onduction was restored. All ECG tracings, including
hythm strips during the procedure, 12-lead ECGs during
isits, and 24-h ambulatory ECGs before closure and at
ollow-up visits were reviewed.In this study, patients with new-onset AVB or aggrava-
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AV Conduction Disturbances in ASD Closure Using ASO May 5, 2004:1677–82ion of a pre-existing AV conduction disturbance were
dentified and defined as patients with AVB. A PR interval
xceeding the upper normal limits for a given age and heart
ate was defined as first-degree AVB (13).
To determine the predisposing factors of AVB, we
ompared the following variables between patients with and
ithout AVB: demographic data, ECG findings before
SD closure (heart rate and PR interval), size of primary
SD, number of multiple ASDs, procedure time, device
ize, device size indexed to body height (device/height), and
ulmonary to systemic flow ratio (Qp/Qs).
In addition, to evaluate the relationship between device
isc and AV node, we measured the distance between the
ight atrial disc and the tricuspid annulus in a standard
chographic apical four-chamber view immediately after
ricuspid valve closure. Results were compared between the
ix patients who received a device 19 mm and developed
VB and a randomly selected group of 23 patients who
eceived a device 19 mm but did not develop AVB.
rotocol of ASD closure. The full description of the ASO
nd the protocol of device closure were reported previously
2,3). In short, all procedures were done under general
nesthesia with continuous transesophageal echocardio-
raphic monitoring. A complete hemodynamic study and
ight pulmonary vein angiography were performed. Trans-
sophageal echocardiography was performed to evaluate the
umber, position, and size of ASDs and surrounding rims.
he defects were balloon-sized using either the Meditech
cclusion Balloon Catheter (Boston Scientific Corp., Wa-
ertown, Massachusetts) until June 1999 or the Amplatzer
izing Balloon (AGA Medical Corp.) thereafter. An oc-
luder was chosen and implanted as reported (2,3). Written,
Abbreviations and Acronyms
ASD  atrial septal defect
ASO  Amplatzer septal occluder
AV  atrioventricular
AVB  atrioventricular block
ECG  electrocardiogram or electrocardiographic
Qp/Qs  pulmonary to systemic flow ratio
able 1. Biometric and Atrial Septal Defect Characteristics of Pa
Patient
Age
(yrs)
Weight
(kg)
Height
(cm)
Number of
ASDs
Primary ASD
Size by TEE
(mm)
1 10.1 28.5 138.0 Fenestrated 4.0
2 3.1 15.2 96.7 1 17.8
3 4.3 14.8 109.8 1 14.0
4 6.9 26.3 106.5 Fenestrated 10.8
5 15.0 62.5 163.0 1 16.0
6 6.8 19.1 122.0 1 16.0
7 2.6 12.4 92.5 1 16.5
8 7.3 15.9 120.3 1 20.5
9 4.9 16.2 106.0 3 5.2
10 5.3 17.4 109.1 1 24.0
˙ ˙SD  atrial septal defect; Qp/Qs  pulmonary to systemic flow ratio; TEE  transesopnformed consent was obtained from all patients and/or
heir guardians.
tatistical analysis. Data are expressed as the mean value
SD or median value (range) for continuous and categor-
cal data, respectively. The unpaired t test was used to
ompare continuous data (demographic, ECG parameters
efore procedure, ASD size, number of ASDs, device size,
evice/height ratio, fluoroscopic time, and procedure time),
nd the Mann-Whitney U test was used in case of non-
ormal distribution. Data distribution was evaluated with
he Kolmogorov-Smirnov normality test. The Fisher exact
est was used for comparison of categorical data (frequencies
f multiple ASDs, device size 19 mm, and indexed size
0.18 mm/cm). A value of p  0.05 was considered
ignificant. All calculations were performed using the sta-
istical package Stat View version 5.0 (SAS Institute Inc.,
ary, North Carolina).
ESULTS
mong the 162 patients, 10 (6.1 %) developed new-onset
VB (n  9) or aggravation of pre-existing first-degree
VB (n 1). Among those, 6 (3.6%) developed second- or
hird-degree AVB (Table 1).
In three patients (Patients 1 to 3), second- or third-
egree AVB was noted during the procedure. Normal AV
onduction resumed spontaneously before the catheters
ere withdrawn in two cases and one month after the
rocedure in the third case, after resuming 1:1 conduction
ith first-degree AVB during the procedure (Figs. 1 and 2).
n the remaining seven patients (Patients 4 to 10), AVB was
rst noted between one day and one week after the
rocedure. The AVB was characterized as first-, second-, or
hird-degree in four, two, and one patient, respectively. In
hese patients, normal AV conduction was restored within
ne month (n  4) and six months (n  1). Two patients
ersisted in first-degree AVB at 12- and 33-month
ollow-up visits. In both cases, however, the PR interval had
mproved compared with its immediate postprocedural
alue (Table 2).
The minimum heart rate in the six patients with second-
s With Atrioventricular Conduction Disturbance
ASD
alloon Size
(mm)
Device
Size
(mm)
Device/
Height
Ratio
Q˙p/Q˙s
Ratio
Associated
Conditions
11.0 18 0.13 0.9 Ebstein’s anomaly
27.0 26 0.27 3.2
21.0 20 0.18 2.7 S/p neuroblastoma
20.8 20 0.19 2.7 Trisomy 21
28.6 34 0.21 1.8
23.5 24 0.20 3.2
23.0 22 0.24 3.4 Pulmonary stenosis
29.3 30 0.25 4.1
15.0 19 0.18 2.8
24.9 28 0.26 2.8tient
Bhageal echocardiography; S/p  status post.
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May 5, 2004:1677–82 AV Conduction Disturbances in ASD Closure Using ASOr third-degree AVB ranged from 39 to 80 beats/min (with
n effective junctional escape rhythm for the two patients in
hird-degree AVB) on 24-h ambulatory ECG monitoring
btained one to seven days after the procedure. No patient
resented with symptoms or hemodynamic compromise
hat required removal of the device or pacemaker implan-
ation.
Seven other patients presented with first-degree AVB
efore ASD closure. Atrioventricular conduction remained
nchanged after the procedure and therefore was not
ncluded in the AVB group, as defined earlier. No patient
as documented to have sinus node dysfunction or second-
r third-degree AVB before the procedure. Five of the seven
igure 2. Echocardiographic apical four-chamber view of the same patient
s in Figure 1. Note the close proximity of the right atrial disc of the
mplatzer device (A) to the tricuspid annulus at the atrioventricular
unction (arrow).
igure 1. Complete atrioventricular block (ventricular rate 74 beats/min) in
nd normal atrioventricular conduction at one-month follow-up (b).oatients remained in first-degree AVB and two were in
ormal AV conduction at final follow-up of 10 to 51
onths. Interestingly, four of these five patients who
emained in first-degree AVB had an underlying disease,
ncluding Steinert myopathy or Holt-Oram syndrome.
There was no significant difference in age, weight, height,
CG findings before the procedure, size of primary ASD,
requency of multiple ASDs, fluoroscopic time, and proce-
ure time between patients with and without AVB (Table
). However, the device size (25  5 vs. 19  6 mm),
evice/height ratio (0.21  0.05 vs. 0.17  0.05 mm/cm),
nd Qp/Qs (2.8  1.0 vs. 2.1  0.8) were significantly
igher in patients with AVB than in those without AVB
Table 3). Among the 10 patients who developed AVB, 9
90%), including all 7 who did so after the procedure,
eceived a device 19 mm. In comparison, 49% of those
ithout AVB received a device 19 mm (p  0.02).
imilarly, 9 of 10 of patients with AVB and all seven
atients who did so after the procedure had a device/height
atio 0.18 mm/cm, compared with 44% of patients with-
ut AVB (p  0.01).
Transthoracic echocardiographic follow-up showed com-
lete ASD closure or a trivial residual shunt in 87% of
atients immediately after and in 93% at one and three
onths after ASO implantation. In this respect, there was
o difference between patients with or without AVB. In
atients in whom a device 19 mm was implanted, there
as no significant difference in distance between the right
trial disc and the tricuspid valve among patients with versus
hose without AVB (6.6  2.0 vs. 6.3  2.5 mm, p  NS)
ISCUSSION
ur retrospective study of a large consecutive series in a
ingle institution indicates that ASD closure using the ASO
an be associated with AVB, which can occur during the
rocedure or immediately after and mandates close ECG
ollow-up. Because hemodynamic compromise was not
year-old patient 24 h after implantation of a 28-mm Amplatzer device (a)a 5-bserved in any of our patients, and spontaneous resolution
o
o
c
(
a
i
d
f
T
w
d
i
A
d
o
t
c
A
o
a
t
o
A
o
(
A
i
p
r
r
s
m
s
ab
le
2.
E
le
ct
ro
ca
rd
io
gr
ap
hi
c
Fi
nd
in
gs
of
P
at
ie
nt
s
W
ho
D
ev
el
op
ed
A
tr
io
ve
nt
ri
cu
la
r
C
on
du
ct
io
n
D
is
tu
rb
an
ce
P
at
ie
nt
B
as
el
in
e
H
ea
rt
R
at
e
(b
ea
ts
/m
in
)
B
as
el
in
e
P
R
In
te
rv
al
(m
s)
T
im
e
of
In
it
ia
l
A
V
B
D
ia
gn
os
is
H
ig
he
st
D
eg
re
e
of
A
V
B
V
en
tr
ic
ul
ar
R
at
e
(b
ea
ts
/m
in
)
T
im
e
to
N
or
m
al
C
on
du
ct
io
n
L
at
es
t
A
V
C
on
du
ct
io
n
F
ol
lo
w
-U
p
(m
on
th
s)
1
92
17
6
D
ur
in
g
pr
oc
ed
ur
e
Se
co
nd
-d
eg
re
e
(W
en
ck
eb
ac
h)
64
*
1
M
on
th
N
or
m
al
P
R
in
te
rv
al
36
2
13
8
11
0
D
ur
in
g
pr
oc
ed
ur
e
Se
co
nd
-d
eg
re
e
(W
en
ck
eb
ac
h)
13
1
Sa
m
e
da
y
N
or
m
al
P
R
in
te
rv
al
28
3
95
12
0
D
ur
in
g
pr
oc
ed
ur
e
T
hi
rd
-d
eg
re
e
93
Sa
m
e
da
y
N
or
m
al
P
R
in
te
rv
al
49
4
11
5
13
2
1
D
ay
Fi
rs
t-
de
gr
ee
(P
R
in
te
rv
al

20
4
m
s)
6
M
on
th
s
N
or
m
al
P
R
in
te
rv
al
9
5
65
17
7
1
D
ay
Fi
rs
t-
de
gr
ee
(P
R
in
te
rv
al

21
1
m
s)
1
M
on
th
s
N
or
m
al
P
R
in
te
rv
al
40
6
11
8
17
2
1
D
ay
Fi
rs
t-
de
gr
ee
(P
R
in
te
rv
al

20
0
m
s)
1
M
on
th
s
N
or
m
al
P
R
in
te
rv
al
30
7
17
1
63
1
D
ay
Se
co
nd
-d
eg
re
e
(P
R
in
te
rv
al

24
0
m
s)
N
ot
re
st
or
ed
Fi
rs
t-
de
gr
ee
A
V
B
12
8
91
14
9
1
W
ee
k
Se
co
nd
-d
eg
re
e
(W
en
ck
eb
ac
h)
48
*
2
W
ee
ks
N
or
m
al
P
R
in
te
rv
al
3
9
10
2
20
0
1
W
ee
k
Se
co
nd
-d
eg
re
e
(W
en
ck
eb
ac
h)
80
*
N
ot
re
st
or
ed
†
Fi
rs
t-
de
gr
ee
A
V
B
33
10
10
0
17
6
1
D
ay
T
hi
rd
-d
eg
re
e
39
*
2
W
ee
ks
N
or
m
al
P
R
in
te
rv
al
4
M
in
im
um
he
ar
t
ra
te
on
24
-h
am
bu
la
to
ry
el
ec
tr
oc
ar
di
og
ra
ph
ic
m
on
ito
ri
ng
;†
Si
nu
s
rh
yt
hm
bu
t
fir
st
-d
eg
re
e
at
ri
ov
en
tr
ic
ul
ar
bl
oc
k.
A
V

at
ri
ov
en
tr
ic
ul
ar
;A
V
B

at
ri
ov
en
tr
ic
ul
ar
bl
oc
k.
T
W
A
B
B
M
M
Q
D
D
P
H
P
Q
*
t
1680 Suda et al. JACC Vol. 43, No. 9, 2004
AV Conduction Disturbances in ASD Closure Using ASO May 5, 2004:1677–82r improvement was observed in all, we advocate close
bservation rather than systematic removal of the device.
Atrioventricular block has been reported after ASD
losure with most of the devices currently or recently in use
Table 4), such as the Cardio-Seal, ASDOS, Angel-Wings,
nd ASO (4,5,10,12,14–16). Although none of those stud-
es was looking specifically at the association of AVB with
evice closure, this occurrence seems to be particularly
requent with the ASO, a finding confirmed in our study.
his comparison is difficult to interpret, however, as it is
idely accepted that the ASO allows the closure of larger
efects than the other devices do. Thus, it might be
nappropriate to conclude whether the characteristics of the
SO (material, shape, size of disks for a specific ASD
iameter) alone are responsible for the increased occurrence
f AVB with the ASO.
Hill et al. (12) systematically obtained 24-hour ambula-
ory ECG monitoring in 41 patients before and after ASD
losure with the ASO and found second- or third-degree
VB in two patients (4.9%). Given the retrospective nature
f our study, 24-h Holter recordings were not obtained
ccording to standard protocol. This may represent a limi-
ation of our study. Nevertheless, the frequency of AVB in
ur study (6.1%, of which 3.7% was second- or third-degree
VB) is comparable, despite the larger size devices used in
ur group of patients. Demkow et al. (5) found one patient
2%) with transient AVB of 50 adult patients who had large
SDs closed using the ASO. The lower frequency of AVB
n their series might be explained by the larger size of
atients, which logically would decrease the device/height
atio, an identified risk factor in our study. Chan et al. (4)
eported one patient with transient AVB in a 100-patient
eries, but the mean size of the device in that study (14.6
m by our calculation) was much smaller than that in this
tudy (19.3 mm).
Indeed, the size of the device can be a predisposing factor
able 3. Comparison Between Patients With and Those
ithout Atrioventricular Conduction Disturbance
Patients
With AVB
(n  10)
Patients
Without AVB
(n  152)
ge (yrs) 6.6  3.7 8.3  7.2
ody weight (kg)* 22.9  14.9 27.4  18.1
ody height (cm) 116  21 121  27
ultiple ASDs (%) 3 (30%) 36 (23.7%)
ain ASD size (mm) 14.6  6.5 14.0  5.8
˙ p/Q˙s ratio* 2.8  0.9† 2.1  0.8
evice size (mm) 24  5† 19  6
evice/height ratio (mm/cm) 0.21  0.04† 0.17  0.05
rocedure time (min)* 87  26 79  33
eart rate (beats/min) 109  27 103  24
R interval (ms) 148  41 145  40
RS duration (ms) 85  12 82  15
Mann-Whitney U test used. †p  0.01 compared with patients without atrioven-
ricular block. Data are presented as the mean value  SD or number (%) of patients.
Abbreviations as in Tables 1 and 2.of AVB after ASD closure. In our study, patients with AVBT *
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May 5, 2004:1677–82 AV Conduction Disturbances in ASD Closure Using ASOeceived significantly larger devices than did patients with-
ut AVB, with the device/height ratio being significantly
igher. Nine (11%) of 83 patients who received devices19
m and 9 (12%) of 75 patients with a device/height ratio
0.18 developed AVB during or after implantation, com-
ared with one (1.2%) of 79 and one (1.1%) of 87 patients,
espectively (p  0.05 each). Thus, patients meeting those
riteria need closer hemodynamic and ECG monitoring of
heir AV conduction immediately after the procedure.
welve-lead ECG periodically and 24-h Holter recordings
re necessary later on, whereas exercise testing may be
equired for selected patients. Chessa et al. (10) reported
hat a patient who showed third-degree AVB with implan-
ation of an 18-mm device had restored normal sinus
hythm after the device was replaced with a 14-mm device.
his again strongly suggests that device size may be an
ndependent risk for AV conduction after ASO implanta-
ion. This emphasizes the importance of the precise sizing
f the ASD to avoid placement of oversized devices.
On the other hand, Du et al. (6) and Hill et al. (12)
eported on the same one patient with preexisting sinus
ode dysfunction who developed complete AVB after ASD
losure using a 24-mm ASO and subsequently required
acemaker implantation (Table 4). To our knowledge, this
s the only reported case requiring pacemaker implantation
fter ASO implantation so far. Pacemaker implantation
aises the question of device retrieval to alleviate AVB. One
ay suggest retrieval in case of second- or third-degree
lock, which occurs during the procedure without sponta-
eous conversion to 1:1 conduction within 30 min. Implan-
ation of a smaller device may then be attempted. This has
ot proven necessary in any of our three patients with
er-procedural AVB, who all improved rather rapidly.
atients with new-onset AVB that first appears after the
rocedure has been completed may be observed in the
ospital until hemodynamic instability is ruled out or
egression of AVB is observed. Subsequent ambulatory
ollow-up with Holter monitoring may be appropriate in
ase of proven hemodynamic stability. In our experience, all
atients with second- or third-degree AVB presented with
able 4. Reported Atrioventricular Conduction Disturbance Asso
Device
Number of
Patients
Mean Age
(yrs)
Stretched
Size
ardio-Seal (13) 50 15.9
SDOS (14) 41 7.8  1.9 14.7  2
ngel Wings (15) 75 28.3 11.9
mplatzer (4) 93 13.3  13.9 14.6 (dev
mplatzer (12)* 41 9.2†
mplatzer (5) 50 40  15.5 18.5
mplatzer (6)* 423 18.1  19.3 17.8  6
mplatzer‡ 162 8.2  7.0 18.4  5
Reported the same patient. †Median value. ‡Our study. Data on mean age and AS
Abbreviations as in Tables 1 and 2.n adequate escape rate, suggesting an intact lower AV node ounction. On the other hand, conversion to 1:1 AV con-
uction has taken up to two weeks in one of our patients.
The mechanism of AVB secondary to ASO implantation
ight be partly attributable to continuous pressure or
riction of atrial discs on the AV node, inducing transient
dema leading to AVB, as suggested by Hill et al. (12).
owever, in our patients in whom devices 19 mm were
mplanted, there was no significant difference in distance
etween the right atrial disc and the tricuspid valve among
atients with versus those without AVB. Assessment of the
eal spatial relationship between atrial discs and the AV
ode using other diagnostic modalities, such as three-
imensional magnetic resonance imaging, may give us more
nsight on this issue.
Preexisting sinus node dysfunction or AV conduction
isturbance should not be ignored, especially in the case of
arge ASDs requiring large devices. It is well known that
SDs may be associated with subclinical ECG abnormali-
ies, including sinus node dysfunction, conduction delay,
nd AV block (17–19). In such cases, thorough ECG
creening, including 24-h ambulatory ECG monitoring,
efore closure of larger ASDs, may be valuable. Use of
orticosteroids to enhance AV conduction recovery is not
upported by experimental data or controlled studies. How-
ver, we used them in our patient with postprocedural
hird-degree AVB. Rapid improvement to second-degree
VB and subsequent full recovery was observed within two
eeks. Whether or not this was a spontaneous or
orticosteroid-enhanced recovery remains uncertain. Like-
ise, the indication for and timing of device retrieval are not
vailable in the literature. If selected because of unstable
VB, device retrieval may not necessarily avoid pacemaker
mplantation.
onclusions. Closure of ASDs using the large ASO can be
ssociated with transient AVB, which occurs during the first
eek of ASD closure and mandates close follow-up. Device
ize19 mm or indexed size0.18 mm/cm seems to be the
ajor predisposing factor. The absence of hemodynamic
ompromise and spontaneous resolution in all our patients
ay justify close observation rather than systematic removal
d With Device Closure of Atrial Septal Defects
Atrioventricular Block Intervention
Transient first-degree AVB  1 None
Transient AVB  4 (third-degree AVB  1) None
Transient third-degree AVB  3 (4%) None
Transient AVB  1 None
Transient second-degree AVB  1,
third-degree AVB  1
Pacemaker*
Transient second-degree AVB  1 None
Third-degree AVB  1 Pacemaker*
Transient second-degree AVB  4,
third-degree AVB  2
None
are presented as the mean value  SD.ciate
ASD
.6
ice)
.2
.9
D sizef the device. Although the outcome of AV conduction has
b
w
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